August NMBio Program on Targeted Cancer Therapeutics: Presentation

Personalized medicine attempts to tailor medical treatment to the individual’s characteristics and in oncology targets an individual’s tumor with a therapy tailored to the specific characteristics of a tumor. Successful development of targeted therapeutics often relies upon co-development with companion diagnostics. Identifying a specific, responsive patient population within a larger population can enable the approval of a therapeutic, but limit its intended use.

Patrick Burke of Myriad Genetics gave a presentation on “Diagnostic Testing for Targeted Cancer Therapeutics”.  Attached for those of you interested is the PowerPoint presentation..NMBio Myriad Presentation August 2015

Comments are closed.

Novo Norodisk

Novo Norodisk

Southwest Labs

Southwest Labs